nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Clinical potential of microdystrophin as a surrogate endpoint
|
Boehler, Jessica F |
|
|
33 |
1 |
p. 40-49 |
artikel |
2 |
Commentary from the Editor
|
Oldfors, Anders |
|
|
33 |
1 |
p. 1-4 |
artikel |
3 |
Correlation between whole body muscle MRI and functional measures in paediatric patients with facioscapulohumeral muscular dystrophy
|
Woodcock, Ian R |
|
|
33 |
1 |
p. 15-23 |
artikel |
4 |
Editorial Board
|
|
|
|
33 |
1 |
p. IFC |
artikel |
5 |
Expanding the phenotype of children presenting with hypoventilation with biallelic TBCK pathogenic variants and literature review
|
Sabanathan, Saraswathy |
|
|
33 |
1 |
p. 50-57 |
artikel |
6 |
Pathogenic variants in three families with distal muscle involvement
|
Weterman, Marian A.J. |
|
|
33 |
1 |
p. 58-64 |
artikel |
7 |
Prevalence of urinary incontinence and other pelvic floor disorders in women with myotonic dystrophy type 1
|
Fisette-Paulhus, Isabelle |
|
|
33 |
1 |
p. 32-39 |
artikel |
8 |
Quantitative vs qualitative muscle MRI: Imaging biomarker in patients with Oculopharyngeal Muscular Dystrophy (OPMD)
|
Melkus, Gerd |
|
|
33 |
1 |
p. 24-31 |
artikel |
9 |
The discovery of the DNA methylation episignature for Duchenne muscular dystrophy
|
Schreyer, Leighton |
|
|
33 |
1 |
p. 5-14 |
artikel |
10 |
265th ENMC International Workshop: Muscle imaging in Facioscapulohumeral Muscular Dystrophy (FSHD): relevance for clinical trials. 22–24 April 2022, Hoofddorp, The Netherlands
|
Monforte, Mauro |
|
|
33 |
1 |
p. 65-75 |
artikel |
11 |
The 2023 version of the gene table of neuromuscular disorders (nuclear genome)
|
Benarroch, Louise |
|
|
33 |
1 |
p. 76-117 |
artikel |
12 |
WMS 2023 Congress announcement
|
|
|
|
33 |
1 |
p. III |
artikel |
13 |
WMS 2023 Flyer
|
|
|
|
33 |
1 |
p. II |
artikel |
14 |
WMS 2023 Information
|
|
|
|
33 |
1 |
p. I |
artikel |